FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: REPORT ON THE PERFORMANCE OF DRUG AND BIOLOGICS FIRMS IN CONDUCTING POSTMARKETING REQUIREMENTS AND COMMITMENTS; AVAILABILITY

WASHINGTON, May 30 -- Food and Drug Administration has issued a notice called: Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Requirements and Commitments; Availability.

The notice was published in the Federal Register on May 30 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA or Agency) is announcing the availability of the Agency's annual report entitled "Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Requirements and Commitments." Under the Federal Food, Drug, and Cosmetic Act (FD&C Act), FDA is required to report annually on the status of postmarketing requirements (PMRs) and p...